FFG
ABBV icon

Floyd Financial Group’s AbbVie ABBV Stock Holding History

Floyd Financial Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.2M Sell
4,361
-209
-5% -$53.6K 0.75% 34
2026
Q2 		$1.12M Sell
4,570
-67
-1% -$14.4K 0.73% 36
2026
Q1 		$966K Buy
4,637
+91
+2% +$20.2K 0.64% 39
2025
Q4 		$1.02M Sell
4,546
-110
-2% -$25.1K 0.69% 41
2025
Q3 		$1.07M Buy
4,656
+115
+3% +$23.4K 0.79% 31
2025
Q2 		$860K Sell
4,541
-590
-11% -$110K 0.79% 29
2025
Q1 		$1.08M Buy
5,131
+710
+16% +$138K 0.97% 29
2024
Q4 		$774K Buy
+4,421
New +$813K 0.64% 38

Other funds holding ABBV

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

Floyd Financial Group's ABBV Position: Q3 2026 in Review

Floyd Financial Group reduced its AbbVie (ABBV) stake by 4.6% in Q3 2026, selling an estimated $53.6K and leaving 4,361 shares worth $1.2M. The position accounts for 0.75% of the portfolio, ranked #34.

Floyd Financial Group first reported a position in ABBV in Q4 2024 and has held it in 8 quarters since. 3,012 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Floyd Financial Group held 4,361 shares of AbbVie worth $1.2M as of Q3 2026.
  • Floyd Financial Group sold 209 AbbVie shares in Q3 2026, an estimated $53.6K.
  • AbbVie made up 0.75% of Floyd Financial Group's portfolio in Q3 2026, its #34 holding.
  • Floyd Financial Group first reported a position in AbbVie in Q4 2024 and has held it in 8 quarters since.
  • 3,012 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Floyd Financial Group's 13F filing for Q3 2026, filed 28 Oct 2026.